Prominent publications by Mercedes Mayos
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT
[ PUBLICATION ]
Late onset Pompe disease (LOPD) is a genetic disorder characterized by slowly progressive skeletal and respiratory muscle weakness. Symptomatic patients are treated with enzyme replacement therapy (ERT) with alglucosidase alpha (rhGAA). Although most of ERT treated patients develop antibodies against rhGAA, their influence on clinical progression is not completely known. We studied the impact of anti-rhGAA antibodies on clinical progression of 25 ERT treated patients. We evaluated ...
|Also Ranks for: Pompe Patients | rhgaa antibodies | antibody titers | muscle function tests | late onset|
Mercedes Mayos: Influence Statistics
Key People For Pompe Patients
Mercedes Mayos:Expert Impact
Concepts for whichMercedes Mayoshas direct influence:Pompe patients, Rhgaa antibodies, Antibodies rhgaa, Muscle function tests, Onset pompe, Enzyme replacement therapy, Enzyme replacement, Antibodies enzyme.
Mercedes Mayos:KOL impact
Concepts related to the work of other authors for whichfor which Mercedes Mayos has influence:Pompe disease, Childhood onset, Enzyme replacement therapy, Muscle mri, Increasing role, Walking distance, Metaanalysis improvement.
Is this your profile? Claim your profile Copy URL Embed Link to your profile